EVOLUS, INC. Increase (Decrease) in Deferred Liabilities
EVOLUS, INC. (EOLS) reported Increase (Decrease) in Deferred Liabilities of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2020-02-25
- EVOLUS, INC. increase (decrease) in deferred liabilities for the quarter ending 2019-12-31 was $0.00.
- EVOLUS, INC. increase (decrease) in deferred liabilities for the quarter ending 2018-12-31 was -$5.00K.
- EVOLUS, INC. increase (decrease) in deferred liabilities for the quarter ending 2018-09-30 was -$3.00K.
- EVOLUS, INC. increase (decrease) in deferred liabilities for the quarter ending 2018-06-30 was -$3.00K.
- EVOLUS, INC. increase (decrease) in deferred liabilities for fiscal 2019 was $0.00.
- EVOLUS, INC. increase (decrease) in deferred liabilities for fiscal 2018 was -$13.00K.
- EVOLUS, INC. increase (decrease) in deferred liabilities for fiscal 2017 was -$6.00K.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 6 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $0.00 10-K · filed 2020-02-25 | ||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-04 | |||
| 2018-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$8.00K derived: sum of 2 quarters · filed 2020-02-25 | -$11.00K derived: sum of 3 quarters · filed 2020-02-25 | -$13.00K 10-K · filed 2020-02-25 |
| 2018-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$6.00K derived: sum of 2 quarters · filed 2019-11-04 | -$8.00K 10-Q · filed 2019-11-04 | -$9.00K derived: sum of 4 quarters · filed 2019-11-04 |
| 2018-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$5.00K 10-Q · filed 2018-08-02 | -$6.00K derived: sum of 3 quarters · filed 2019-03-20 | -$9.00K derived: sum of 4 quarters · filed 2019-03-20 |
| 2018-03-31 | -$2.00K 10-Q · filed 2018-05-10 | -$3.00K derived: sum of 2 quarters · filed 2019-03-20 | -$6.00K derived: sum of 3 quarters · filed 2019-03-20 | -$8.00K derived: sum of 4 quarters · filed 2019-03-20 |
| 2017-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-20 | -$4.00K derived: sum of 2 quarters · filed 2019-03-20 | -$6.00K derived: sum of 3 quarters · filed 2019-03-20 | -$6.00K 10-K · filed 2019-03-20 |
| 2017-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | -$5.00K derived: sum of 2 quarters · filed 2018-11-05 | -$5.00K 10-Q · filed 2018-11-05 | |
| 2017-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$2.00K 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |